
1. Technology overview
Heuron Co., Ltd. was founded in 2017 and is headquartered in Seoul, South Korea, with offices in San Jose (US) and Singapore. The company develops medical AI for neurological disorders, focusing on acute stroke and neurodegenerative disease imaging.
Heuron StroCare Suite analyzes non-contrast CT images to detect suspected intracranial hemorrhage (ICH) and large vessel occlusion (ELVO) and to calculate ASPECTS scores, with additional CT angiography (CTA) and CT perfusion (CTP) modules. Analysis completes within minutes, notifies clinicians of critical findings, and results can be checked through PACS.
2. Highlighted features & specifications
- Heuron ICH: Detects suspected intracranial hemorrhage on non-contrast head CT for triage.
- Heuron ELVO: Identifies suspected large vessel occlusion on non-contrast CT.
- Heuron ASPECTS: Identifies brain regions and calculates ASPECTS scores from non-contrast CT.
- Heuron CTA and CTP: Analyze CT angiography and CT perfusion, with CTP reporting CBF, CBV, MTT, Tmax and mismatch.
- Notification and PACS: Alerts clinicians to critical findings and shows results through PACS and a viewer.
- Reports: Individual reports can be saved or printed to share with patients.
3. Potential application
Emergency departments of provincial hospitals in Vietnam can use CT-based triage to flag hemorrhage and large vessel occlusion before radiologist review. Hub-and-spoke stroke networks can route suspected thrombectomy candidates from primary centers to capable centers.
4. Benefits
Prioritizes emergency stroke patients through automatic triage and notification of critical findings. Analysis completes within minutes on non-contrast CT, which is available at most hospitals. Results are viewable in existing PACS and can be printed as reports. Regulatory approvals in several Asian markets ease adoption.
5. Market trends & opportunities
Stroke care depends on fast imaging triage, and hospitals across Asia are adopting AI to shorten time to diagnosis. Southeast Asian regulators such as Malaysia's MDA and Singapore's HSA have begun approving Korean stroke AI, opening a route for similar tools in Vietnam's stroke centers.
6. Other information
Founded 2017, Seoul. Series D of KRW 5 billion in 2025, Japan PMDA approval for StroCare Suite in 2025, Thailand joint venture, ISO 13485 and ISO 27001 certified. Distributors in Thailand and Taiwan, Raffles Hospital supply contract.
One platform connecting startups, corporations, research institutions, regions and investors











Playbook & Handbook · February 6, 2026
Winning Accelerator Playbook 2026 by BambuUP
RETAIL E-COMMERCE: AI AND REAL-TIME DATA ARE TRANSFORMING HOW RETAIL BUSINESSES OPERATE








































